{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:39:17Z","timestamp":1792687157676,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1053\/j.ajkd.2026.06.028","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:57:54Z","timestamp":1792684674000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes Following Kidney Failure From IgA Nephropathy Compared to Diabetic Kidney Disease and Other Glomerular Diseases"],"prefix":"10.1053","author":[{"given":"Soumita","family":"Bagchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Teixeira-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Scholes-Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.ajkd.2026.06.028_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-Term Outcomes in IgA Nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2026.06.028_bib2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1523-1755.2004.00833.x","article-title":"Clinicopathologic correlations of renal pathology in Spain","volume":"66","author":"Rivera","year":"2004","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.ajkd.2026.06.028_bib3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.34067\/KID.0005882022","article-title":"The Cleveland Clinic Kidney Biopsy Epidemiological Project","volume":"3","author":"Bobart","year":"2022","journal-title":"Kidney360"},{"issue":"3","key":"10.1053\/j.ajkd.2026.06.028_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.34067\/KID.0000000000000379","article-title":"Kidney Failure Events, Cardiovascular Disease Events, and All-Cause Mortality in Patients with IgA Nephropathy in a Real-World Database","volume":"5","author":"Lerma","year":"2024","journal-title":"Kidney360"},{"issue":"5","key":"10.1053\/j.ajkd.2026.06.028_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/nep.12629","article-title":"Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study","volume":"21","author":"Zhang","year":"2016","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"10.1053\/j.ajkd.2026.06.028_bib6","article-title":"Kidney Failure Attributed to Immunoglobulin A Nephropathy: A USRDS Retrospective Cohort Study of Epidemiology, Treatment Modalities, and Economic Burden","volume":"6","author":"Bensink","year":"2024","journal-title":"Kidney Med"},{"issue":"4","key":"10.1053\/j.ajkd.2026.06.028_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.mcna.2023.03.004","article-title":"Diabetic Kidney Disease: An Update","volume":"107","author":"Gupta","year":"2023","journal-title":"Med Clin North Am"},{"issue":"10032","key":"10.1053\/j.ajkd.2026.06.028_bib8","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(16)00272-5","article-title":"Primary glomerulonephritides","volume":"387","author":"Floege","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1053\/j.ajkd.2026.06.028_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2023.151435","article-title":"Glomerular Diseases Across Lifespan: Key Differences in Diagnostic and Therapeutic Approaches","volume":"43","author":"Windpessl","year":"2023","journal-title":"Semin Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2026.06.028_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.kint.2025.04.003","article-title":"Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)","volume":"108","author":"Floege","year":"2025","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2026.06.028_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MNH.0000000000001105","article-title":"IgA nephropathy: a paradigm shift in treatment strategies","volume":"34","author":"Roberts","year":"2025","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1053\/j.ajkd.2026.06.028_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12882-025-03953-3","article-title":"New insights in the treatment of DKD: recent advances and future prospects","volume":"26","author":"Zhao","year":"2025","journal-title":"BMC Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2026.06.028_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2025.101133","article-title":"New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases","volume":"7","author":"Mushailov","year":"2025","journal-title":"Kidney Medicine"},{"issue":"2","key":"10.1053\/j.ajkd.2026.06.028_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14020584","article-title":"New Treatment Regimens, New Drugs, and New Treatment Goals for Lupus Nephritis","volume":"14","author":"Rossi","year":"2025","journal-title":"J Clin Med"},{"issue":"Supplement_1","key":"10.1053\/j.ajkd.2026.06.028_bib15","doi-asserted-by":"crossref","first-page":"i15","DOI":"10.1093\/rheumatology\/keae663","article-title":"Emerging targeted therapies in ANCA-associated vasculitis","volume":"64","author":"Jayne","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.ajkd.2026.06.028_bib16","unstructured":"Australia & New Zealand\u2019s registries for organ replacement therapy. Accessed 10 December, 2025. https:\/\/anzorrg.org.au\/?s=appendix+1&data-group=anzdata#uagb-tabs__tab3"},{"key":"10.1053\/j.ajkd.2026.06.028_bib17","unstructured":"Statistics ABo. Index of Relative Socio-economic Advantage and Disadvantage (IRSAD). Accessed 10 December, 2025. https:\/\/www.abs.gov.au\/statistics\/people\/people-and-communities\/socio-economic-indexes-areas-seifa-australia\/latest-release#index-of-relative-socio-economic-advantage-and-disadvantage-irsad-"},{"issue":"9","key":"10.1053\/j.ajkd.2026.06.028_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2025.101061","article-title":"Socioeconomic Disadvantage, All-Cause and Cause-Specific Mortality in Patients Treated With Maintenance Dialysis: A Mediation Analysis of Geographical Inequity and Multimorbidity","volume":"7","author":"Boroumand","year":"2025","journal-title":"Kidney Med"},{"key":"10.1053\/j.ajkd.2026.06.028_bib19","unstructured":"Statistics ABo. Australian Statistical Geography Standard (ASGS) Edition 3. Accessed 10 December, 2025. https:\/\/www.abs.gov.au\/statistics\/standards\/australian-statistical-geography-standard-asgs-edition-3\/jul2021-jun2026\/remoteness-structure\/remoteness-areas"},{"key":"10.1053\/j.ajkd.2026.06.028_bib20","unstructured":"Statistics ABo. Population. Accessed 10 December, 2025. https:\/\/www.abs.gov.au\/statistics\/people\/population"},{"issue":"8","key":"10.1053\/j.ajkd.2026.06.028_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256522","article-title":"Primary kidney disease modifies the effect of comorbidities on kidney replacement therapy patients' survival","volume":"16","author":"Helve","year":"2021","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2026.06.028_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jclinepi.2022.05.021","article-title":"Avoiding overadjustment bias in social epidemiology through appropriate covariate selection: a primer","volume":"149","author":"van Zwieten","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8","key":"10.1053\/j.ajkd.2026.06.028_bib23","doi-asserted-by":"crossref","first-page":"e1378","DOI":"10.1016\/S2214-109X(25)00198-6","article-title":"Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023","volume":"13","author":"GBDKFwRT","year":"2025","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1053\/j.ajkd.2026.06.028_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/nep.14134","article-title":"Trends in the incidence of renal replacement therapy by type of primary kidney disease in Japan, 2006-2020","volume":"28","author":"Wakasugi","year":"2023","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"10.1053\/j.ajkd.2026.06.028_bib25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ekir.2023.12.012","article-title":"Barriers to Care: New Medications and CKD","volume":"9","author":"Kim","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"9","key":"10.1053\/j.ajkd.2026.06.028_bib26","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/ndt\/gfae034","article-title":"Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry","volume":"39","author":"Abd","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2026.06.028_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2215\/CJN.0000000607","article-title":"An International Study of Variation in Attitudes to Kidney Biopsy Practice","volume":"20","author":"Toal","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1053\/j.ajkd.2026.06.028_bib28","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/ckj\/sfad199","article-title":"Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis","volume":"16","author":"Lee","year":"2023","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1053\/j.ajkd.2026.06.028_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ckj\/sfy128","article-title":"World Kidney Day Steering C. Burden, access and disparities in kidney disease","volume":"12","author":"Crews","year":"2019","journal-title":"Clin Kidney J"},{"issue":"7","key":"10.1053\/j.ajkd.2026.06.028_bib30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.34067\/KID.0000000000000489","article-title":"The Future of Kidney Care in Low- and Middle-Income Countries: Challenges, Triumphs, and Opportunities","volume":"5","author":"Kalyesubula","year":"2024","journal-title":"Kidney360"},{"issue":"7","key":"10.1053\/j.ajkd.2026.06.028_bib31","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2215\/CJN.11261114","article-title":"Patient characteristics and outcomes by GN subtype in ESRD","volume":"10","author":"O'Shaughnessy","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2026.06.028_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/08860220500234832","article-title":"Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy","volume":"27","author":"Batista","year":"2005","journal-title":"Ren Fail"},{"issue":"3","key":"10.1053\/j.ajkd.2026.06.028_bib33","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/ckj\/sfaa029","article-title":"Spatiotemporal trends and prognosis of end-stage renal disease patients with biopsy-proven immunoglobulin A nephropathy in France from 2010 to 2014","volume":"14","author":"Robert","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1053\/j.ajkd.2026.06.028_bib34","unstructured":"Australia & New Zealand Dialysis & Transplant Registry. ANZDATA Web API v2026.2.3.0. https:\/\/services.anzdata.org.au\/webservices\/doc\/post-api-patient-add"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626011820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626011820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:57:59Z","timestamp":1792684679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626011820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S0272638626011820"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.06.028","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes Following Kidney Failure From IgA Nephropathy Compared to Diabetic Kidney Disease and Other Glomerular Diseases","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}